Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Neoplasms × Amines × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Lymphoid 1 Dermatologic 1

Conditions

Mycosis Fungoides 6 Lymphoma, T-Cell, Cutaneous 4 Neoplasms 1 Dermatitis, Contact 1

Interventions

pembrolizumab 156 Gemcitabine 141 Paclitaxel 131 Carboplatin 119 Bevacizumab 114 Surveys and Questionnaires 99 Cyclophosphamide 97 Cisplatin 97 Docetaxel 96 Blood Specimen Collection 92 Exercise 90 Nivolumab 85 Capecitabine 78 Fluorouracil 77 Dexamethasone 73 Radiotherapy 70 Irinotecan 64 Standard of Care 60 Pemetrexed 59 Oxaliplatin 59 Drug Therapy 56 Leucovorin 55 Cetuximab 49 Erlotinib Hydrochloride 46 atezolizumab 45 Sorafenib 45 Doxorubicin 44 Interviews as Topic 43 Ipilimumab 38 130-nm albumin-bound paclitaxel 38

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02296164 2020-03-04

PROVe

Helsinn Therapeutics (U.S.), Inc

300 enrolled 7 charts

DermatologicLymphoid

Mycosis Fungoides, Neoplasms, Lymphoma, T-Cell, Cutaneous

Data powered by HemOnc (CC BY 4.0) Colophon ⚡